Professional Summary
Professional Overview
Georg Schultze is a seasoned business leader and entrepreneur with extensive experience in the pharmaceutical and life sciences industries. As a Co-Founder of Anstalt für Zellforschung and Founder of Zellaforte Pharma Holding GmbH, he leverages his deep industry expertise to drive innovation and strategic growth. Additionally, he serves as a Senior Advisor at Houlihan Lokey, providing valuable guidance and counsel to clients.
Experience Summary
Current Roles
Co-Founder, Anstalt für Zellforschung (2016-01-01 to Present)
- Co-founded a leading research institute focused on advancing cell-based therapies and regenerative medicine
- Providing strategic leadership and oversight to drive the organization's research agenda and collaborations
- Securing funding and partnerships to accelerate the development and commercialization of innovative cell-based solutions
Founder, Zellaforte Pharma Holding GmbH (2016-01-01 to Present)
- Established a pharmaceutical holding company to invest in and commercialize promising cell-based therapies
- Responsible for identifying, evaluating, and acquiring potential portfolio companies
- Overseeing the strategic direction, financing, and operational execution of the holding company's investments
Senior Advisor, Houlihan Lokey (2021-12-01 to Present)
- Providing strategic advisory services to clients in the healthcare and life sciences sectors
- Leveraging deep industry knowledge and networks to support clients in navigating complex transactions and market dynamics
- Collaborating with cross-functional teams to develop tailored solutions that drive value for clients
Career Progression
Senior Advisor, GCA Altium (2020-03-01 to 2021-11-01)
- Served as a senior advisor to the firm, offering strategic guidance and industry expertise to clients
- Contributed to the successful execution of M&A and capital raising transactions in the life sciences sector
Vorstand/Director, GCA Altium (2000-01-01 to 2020-02-01)
- Held leadership roles within the firm, including serving as a Director and member of the management board
- Spearheaded the firm's expansion into the healthcare and life sciences sectors, building a strong track record of successful transactions
Non-Executive Director, IBIS Capital (2007-02-01 to 2020-01-01)
- Served on the board of directors, providing strategic oversight and guidance to the firm
- Contributed to the firm's growth and diversification into new investment areas, including the life sciences industry
Academic Background
Georg Schultze holds a Master's degree in Business Administration and Finance from a leading European university. His academic background provides a strong foundation for his strategic and financial expertise in the pharmaceutical and life sciences sectors.
Areas of Expertise
- Strategic advisory and transaction execution in the healthcare and life sciences industries
- Pharmaceutical and biotechnology industry knowledge, with a focus on cell-based therapies and regenerative medicine
- Venture capital and private equity investments in emerging life sciences companies
- Organizational leadership and operational management of research institutes and pharmaceutical holding companies
Professional Impact
- Co-founded Anstalt für Zellforschung, a leading research institute driving advancements in cell-based therapies and regenerative medicine
- Established Zellaforte Pharma Holding GmbH to invest in and commercialize innovative cell-based therapies
- Advised clients on numerous successful M&A and capital raising transactions in the life sciences sector, creating significant value for stakeholders
Conclusion
With a diverse background spanning entrepreneurship, investment, and advisory roles, Georg Schultze has established himself as a respected and influential figure in the pharmaceutical and life sciences industries. His deep industry expertise, strategic acumen, and track record of driving innovation and value creation position him as a valuable asset to his clients and portfolio companies.
